Koers Med Biogene Inc Toronto S.E.
Aandelen
MBI
CA58402B1076
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 130K 177K 120K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 0 | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 407 554,58 375,29 | Nettoliquiditeiten 2023 | 713 971,53 657,45 | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-4,96
x | K/w-verhouding 2023 |
-2,24
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05-09-14 |
Ibrahim Ghobrial
DFI | Director of Finance/CFO | - | 05-09-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Toby Weir-Jones
BRD | Director/Board Member | - | 05-09-14 |
Iain Weir-Jones
CEO | Chief Executive Officer | - | 05-09-14 |
David Diebolt
BRD | Director/Board Member | - | 05-09-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-38,56% | 8,39 mld. | |
+0,18% | 3,32 mld. | |
+9,29% | 2,49 mld. | |
-18,21% | 2,06 mld. | |
-24,57% | 1,59 mld. | |
+32,37% | 1,15 mld. | |
-7,64% | 704 mln. | |
+8,42% | 678 mln. | |
-29,59% | 508 mln. |